The impact of conflicts of interest in plastic surgery: An analysis of acellular dermal matrix, implant-based breast reconstruction

Plastic and Reconstructive Surgery

Volumn 133, Issue 6, 2014, Pages 1328-1334

  Lopez, Joseph ^a,b   Prifogle, Erin ^b   Nyame, Theodore T ^b   Milton, Jacqueline ^b   May, James W ^b  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACELLULAR DERMAL MATRIX; ADULT; AGED; ARTICLE; BREAST AUGMENTATION; CONFLICT OF INTEREST; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; HUMAN; MASTECTOMY; METHODOLOGY; MIDDLE AGED; REOPERATION; SKIN TRANSPLANTATION; STATISTICAL MODEL; TREATMENT FAILURE;

ACELLULAR DERMIS; ADULT; AGED; BREAST IMPLANTATION; CONFLICT OF INTEREST; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; LOGISTIC MODELS; MASTECTOMY; MIDDLE AGED; REOPERATION; SKIN TRANSPLANTATION; TREATMENT FAILURE;

EID: 84902179914     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Thompson DF. Understanding financial conflicts of interest.N Engl J Med. 1993;329:573-576.
2. Dorsey ER, de Roulet J, Thompson JP, et al. Funding of USbiomedical research, 2003-2008. JAMA 2010;303:137-143.
3. Moses H III, Martin JB. Academic relationships withindustry: A new model for biomedical research. JAMA2001;285:933-935.
4. Friedman LS, Richter ED. Relationship between conflictsof interest and research results. J Gen Intern Med. 2004;19:51-56.
5. Peppercorn J, Blood E, Winer E, Partridge A. Associationbetween pharmaceutical involvement and outcomes inbreast cancer clinical trials. Cancer 2007;109:1239-1246.
6. Bhandari M, Busse JW, Jackowski D, et al. Association betweenindustry funding and statistically significant pro-industryfindings in medical and surgical randomized trials. CMAJ2004;170:477-480.
7. Kjaergard LL, Als-Nielsen B. Association between competinginterests and authors' conclusions: Epidemiologicalstudy of randomised clinical trials published in the BMJ. BMJ2002;325:249.
8. Leopold SS, Warme WJ, Fritz Braunlich E, Shott S. Associationbetween funding source and study outcome in orthopaedicresearch. Clin Orthop Relat Res. 2003;415:293-301.
9. Brown A, Kraft D, Schmitz SM, et al. Association of industrysponsorship to published outcomes in gastrointestinal clinicalresearch. Clin Gastroenterol Hepatol. 2006;4:1445-1451.
10. Bekelman JE, Li Y, Gross CP. Scope and impact of financialconflicts of interest in biomedical research: A systematicreview. JAMA 2003;289:454-465.
11. Clough KB, O'Donoghue JM, Fitoussi AD, Nos C, FalcouMC. Prospective evaluation of late cosmetic results followingbreast reconstruction: I. Implant reconstruction. PlastReconstr Surg. 2001;107:1702-1709.
12. Gabriel SE, Woods JE, O'Fallon WM, Beard CM, Kurland LT,Melton LJ III. Complications leading to surgery after breastimplantation. N Engl J Med. 1997;336:677-682.
13. Kjøller K, Hölmich LR, Jacobsen PH, et al. Epidemiologicalinvestigation of local complications after cosmetic breastimplant surgery in Denmark. Ann Plast Surg. 2002;48:229-237.
14. O'Brien W, Hasselgren PO, Hummel RP, et al. Comparisonof postoperative wound complications and early cancerrecurrence between patients undergoing mastectomy withor without immediate breast reconstruction. Am J Surg. 1993;166:1-5.
15. Als-Nielsen B, Chen W, Gluud C, Kjaergard LL. Associationof funding and conclusions in randomized drug trials:A reflection of treatment effect or adverse events JAMA2003;290:921-928.
16. Baker CB, Johnsrud MT, Crismon ML, Rosenheck RA, WoodsSW. Quantitative analysis of sponsorship bias in economicstudies of antidepressants. Br J Psychiatry 2003;183:498-506.
17. Okike K, Kocher MS, Mehlman CT, Bhandari M. Conflictof interest in orthopaedic research: An association betweenfindings and funding in scientific presentations. J Bone JointSurg Am. 2007;89:608-613.
18. Zuckerman JD, Prasarn M, Kubiak EN, Koval KJ. Conflictof interest in orthopaedic research. J Bone Joint Surg Am. 2004;86:423-428.
19. Chi JH. Exposing conflicts of interest and complications ofrhBMP-2. Neurosurgery 2011;69:N21-N22.
20. Hirsch L. Randomized clinical trials: What gets published,and when CMAJ 2004;170:481-483.
21. Kennedy D. The old file-drawer problem. Science 2004;305:451.
22. Carty MJ, Chan R, Huckman R, Snow D, Orgill DP. A detailedanalysis of the reduction mammaplasty learning curve: A statisticalprocess model for approaching surgical performanceimprovement. Plast Reconstr Surg. 2009;124:706-714.
23. Lee BT, Tobias AM, Yueh JH, et al. Design and impact ofan intraoperative pathway: A new operating room model forteam-based practice. J Am Coll Surg. 2008;207:865-873.
24. Orlowski JP, Wateska L. The effects of pharmaceutical firmenticements on physician prescribing patterns: There's nosuch thing as a free lunch. Chest 1992;102:270-273.
25. Lexchin J. Interactions between physicians and the pharmaceuticalindustry: What does the literature say CMAJ1993;149:1401-1407.
26. Wazana A. Physicians and the pharmaceutical industry: Is agift ever just a gift JAMA 2000;283:373-380.